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ABSTRACT 
Disparity in access to health care and preventive services places a heavier burden of 
morbidity on those with limited access and resources. Underserved populations with 
decreased access to appropriate health screening and therapeutic interventions often 
present with increased risks for peripheral arterial disease. Some patients with peripheral 
arterial disease are asymptomatic and may defer treatment while others present with 
occlusive disease requiring immediate therapy. Delaying diagnosis and treatment reduces 
quality of life and functional status. The prevalence of peripheral arterial disease has been 
extensively studied in the elderly population but the prevalence in the high-risk 
underserved population is unknown. The purpose of this study was to identify the 
prevalence of peripheral arterial disease in an underserved, high-risk, predominantly 
African American population and to determine if providers using an electronic blood 
pressure machine could accurately measure the ankle-brachial index. The sample 
population of forty adult residents at a homeless shelter in northeast Florida was screened 
for peripheral arterial disease. Inclusion criteria consisted of a diagnosis of hypertension, 
hyperlipidemia, diabetes or a history of smoking. The ankle-brachial index was assessed 
using the vascular Doppler method and an electronic blood pressure machine though the 
latter was found to be an insensitive screening tool. The ankle-brachial index, the San 
Diego Claudication Questionnaire and a physical assessment were used in this cross-
sectional study to determine the prevalence of peripheral arterial disease. An abnormal 
ankle-brachial index value (:S 0. 90), indicating a high suspicion of peripheral arterial 
disease, was assessed in 22.5% ofthe sample population, all of whom were found to have 
a history of smoking crack cocaine. 
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CHAPTER ONE 
INTRODUCTION 
Peripheral arterial disease (PAD) is significant, largely undiagnosed and 
undertreated in primary care practice (Treat-Jacobson & Walsh, 2003). High-risk 
underserved populations, with limited access to appropriate health screenings or 
therapeutic interventions often present with multiple complications that contribute to 
PAD, a manifestation of systemic atherosclerosis. Most patients with PAD are 
asymptomatic but their risk of cardiovascular events and death is equal to that of patients 
with symptomatic disease (Khunti, 2003). 
1 
The diagnosis and treatment of this disease poses challenges as most health care 
providers' link atherosclerosis with heart disease and not necessarily PAD. Primary care 
providers can readily identify the classic presentation of acute myocardial infarction 
(AMI) and linlc the problem with coronary artery disease. Most are able to explain the 
pathophysiology of the disease as an inflammatory process leading to atherosclerotic 
deposits narrowing coronary arteries. Total myocardial arterial occlusion may ensue 
causing tissue necrosis leading to significant morbidity and mortality. Prevention and 
detection of heart disease and its risks are commonplace. Yet, how many could recognize 
that a patient presenting with classic signs and symptoms of AMI may also have 
peripheral arterial disease? 
Diehm et al. (2004) acknowledge that PAD prevalence data in primary care is 
limited despite its vital impotiance to improve treatment outcomes. Experts call for the 
development of enhanced PAD screening strategies to reduce the risks of cardiovascular 
and cerebrovascular events in the community. 
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PAD is a progressive occlusion of the arteries supplying the peripheral 
vasculature (Bordeaux, Reish, & Hirsch, 2003; Schainfeld, 2001). The carotid, abdominal 
and lower extremity arteries are commonly affected by this disease. Stiihlinger and Tsao 
(2003) describe PAD as a process whereby the affected vessel lumen narrows or becomes 
obstructed impeding normal metabolic processes ultimately leading to significant 
peripheral arterial occlusion. The pathogenesis of PAD is atherosclerosis, the same 
disease that causes narrowing of coronary arteries leading to acute myocardial infarction. 
This study addresses the significant problem oflower extremity PAD and its 
impact on a high risk, underserved, predominantly homeless African American 
population residing in a north east Florida homeless shelter. The important role of 
primary care providers, particularly the role of the primary care nurse practitioner in 
identifying PAD by screening for the disease using the ankle brachial index (ABI) is 
delineated. 
Background 
Sources vary but most report that 8-12 million Americans are affected by PAD 
(Lesho, Manngold & Gey, 2004; Hirsch, Criqui, Treat-Jacobson, Regensteiner, et.al, 
2001). Prevalence data for PAD is equal for men and women and ranges from 12- 20% 
according to the American Heart Association (n.d.) however Hirsch et al. reported a 
prevalence of29% (2001) in a sample population with an average age over 70 years. 
3 
Based on data from the National Health and Nutrition Examination Survey 1999-2000, 
the prevalence among U.S. residents 2:40 years was 4.3% or approximately 5 million 
people (Selvin & Edinger, 2004). Age is a major risk factor, as is the presence of diabetes 
mellitus and smoking. Other important risk factors include poorly controlled 
hypertension, hyperlipidemia, C-reactive protein and hyperhomocysteinemia (Schainfeld, 
2001). 
More than 20% of those with PAD experience walking induced intermittent 
claudication in the lower back, buttock, hip, thigh, calf or foot arch of one or both legs 
that diminishes with rest (Comerota, 2003). Intermittent claudication is pain that can be 
described as cramping, burning or aching and may cause numbness (Meru, Mittra, 
Thyagarajan & Chugh, in press). The severity may increase over time and the disease 
progressively blocks blood flow in the affected extremity. Collateral circulation may 
ensue effectively bypassing the narrowed artery limiting symptoms in some individuals 
3with PAD. In others, the severity of PAD slowly increases causing limitations and up to 
4% of those with the disease may require amputation (Sheehan, et al., 2003). Conducting 
a history and physical exam helps the provider diagnose symptomatic PAD. History of 
cigarette smoking, diabetes, hypertension and hyperlipidemia raise suspicion for the 
disease. Differential diagnoses include spinal stenosis, lumbar disk disease, diabetic 
neuropathy and arterial embolism. 
Obtaining an ankle-to-arm ratio of systolic blood pressure using a standard blood 
pressure cuff and a hand held Doppler device is a useful screening tool for PAD (Hirsch, 
Gloviczki, Drooz, Lovell & Creager, 2004; Leng, Fowkes, Lee & Dunbar, et al.1996; 
Sheehan et al., 2003). Those with abnormal screening ratios for PAD are referred to 
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specialists for further workup, diagnosis and treatment. Specialists rule out other causes 
of pain through careful questioning and physical examination. Diagnosis of PAD is often 
done by an interventional radiologist who performs a catheterization and injects contrast 
material into the abnormal blood vessels. Radiographs by digital subtraction angiography 
or a video are obtained. Areas of vascular stenosis are reviewed in conjunction with 
history and physical findings. 
Stenotic vessels should be initially managed with exercise training and risk factor 
modification but can also be treated pharmacologically (Lesho, Manngold & Gey 2004) 
or by a variety oftechniques including balloon angioplasty, stents, bypass surgery, and 
grafts (Seiggreen & Kline, 2004). Medical management often includes antiplatelet 
therapy, medications that decrease vascular viscosity/ promote vessel flexibility and 
anticoagulants. 
Role of Health Care Providers 
Physicians, nurse practitioners, registered nurses and other medical and nursing 
staff are responsible for detecting those at risk for PAD. Primary care providers, such as 
family physicians and family nurse practitioners play a critical role in the screening and 
diagnosis of PAD. Experienced nurses, specifically trained in Doppler ultrasound 
assessment can incorporate this vital procedure into routine evaluation of patients at risk 
for atherosclerosis and PAD. A high index of suspicion is needed in this setting as nearly 
70% of the patients are asymptomatic. Khunti (2003) suggests that screening should be 
targeted to smokers and persons with hypertension, diabetes, and hypercholesterolemia. 
The National Heart Lung and Blood Institute workshop also identified elevated 
fibrinogen, hyperhomocysteinemia and increased C-reactive protein as PAD risk factors 
(2003). In underserved populations, these known risks for cardiovascular disease and 
PAD often go undetected and untreated (Politzer, Schempf, Starfield, & Shi, 2003), 
progressively damaging the vasculature. 
It is important that all involved in detection of PAD know that the ABI may be 
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falsely elevated, especially in long-term diabetics and may signify non-compressible 
arteries due to calcification (Fahey, 1999; Sheehan et al, 2003). Accuracy of results may 
be limited in renal failure, obesity, systolic heart failure and vascular calcification. 
Therefore, the diagnosis of PAD may be missed. Annual ABI measurements may aid 
prognosis, particularly in patients without classic symptoms due to peripheral neuropathy 
(Wasserman, 2001). According to Ouriel (2001), Doppler ankle-brachial index screening 
should be routinely incorporated into the diagnostic workup when evaluating patients at 
risk for atherosclerosis. Aggressive management of modifiable risk factors and 
antiplatelet therapy are secondary and tertiary prevention strategies for PAD patients 
(Hiatt, 2001). 
Problem 
The National Heart Lung and Blood Institute (NHLBI) (2003) identified PAD as a 
significant health problem that is under-recognized. There are many barriers to diagnosis 
of PAD including a lack of familiarity with typical symptoms, restriction of time spent 
with patients in the primary care setting, inability to perform screening measures and 
limited referrals to specialists. The ABI is a quantitative assessment of the severity of 
PAD in nearly all affected individuals, whether or not they are symptomatic (Goodal, 
2000). Although obtaining an ABI is non-invasive, inexpensive and well-tolerated (De 
Sanctis, 2001), many primary care providers do not perform the test themselves nor do 
they refer patients for screening resulting in the problem of under-diagnosis and under-
treatment. 
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Screening for PAD in underserved or homeless populations is more difficult to 
accomplish because these individuals may not seek care. Additionally, providers may not 
think about PAD screening when a homeless patient presents for another problem. 
Primary care providers need to be aware of the asymptomatic nature of PAD in the 
underserved in general and have a high index of suspicion for the disease. Identifying 
those with known risk factors for cardiovascular disease is paramount in this population 
(Politzer, Schempf, Starfield, & Shi, 2003). 
Purpose & Research Questions 
The purpose of this cross-sectional, descriptive study was twofold. The first goal 
was to determine the prevalence of PAD in a high-risk, underserved, predominantly 
African American, homeless population. The second goal was to determine if the 
electronic blood pressure (oscillometric) machine (EBM) could accurately measure ABI 
compared to findings obtained by Doppler technique. 
Two research questions were addressed in this study. The first asked "What is the 
prevalence of peripheral arterial disease in the target population" and the second asked 
"What is the efficacy of using an EBM versus a Doppler for ABI screening?" Efficacy in 
this setting means the ability of the EBM to obtain the same result as the Doppler for 
ABI. 
Variables 
The antecedent variables were the participant's gender, pre-existing disease 
status, ethnicity, physical assessment, claudication questionnaire results and smoking 
status. The predictor variables were age, blood pressure, fasting blood glucose, 
glycosylated hemoglobin level (HgbAlc), total cholesterol, low-density lipoprotein level 
(LDL), pack-year history and ABI. The ABI ratio is the criterion variable for which the 
first research question is based. The following theoretical and operational definitions 
were used. 
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Diabetes. Diabetes mellitus (DM) is any of a variety of abnormal conditions 
characterized by inadequate secretion or inefficient utilization of insulin, over-production 
of urine, excess glucose found in blood or urine and insatiable thirst. DM is a disorder of 
carbohydrate metabolism due to heredity or environmental factors (Pease, 2002). In this 
study, previously documented DM operationally confirmed presence of the disease and 
level of diabetic control was measured by fasting blood glucose and HgbA 1 C. 
Hypertension. Hypertension is arterial blood pressure that is abnormally high. For the 
purpose of this study, prehypertension, stage 1 hypertension and stage 2 hypertension 
based on the Seventh Report of the Joint National Committee (JNC 7) will categorically 
define hypertension. Patients with a systolic pressure of 120-139 mmHg or a diastolic 
pressure of 80-89 mmHg are considered pre-hypertensive. Stage 1 hypertension is 
indicated by a systolic of 140-159 mmHg or a diastolic of90-99 mmHg and Stage 2 by a 
systolic ?:160 mmHg and a diastolic ?:100 mmHg. (U.S. Department of Health and 
Human Services, 2004). The ADA suggests that diagnosed diabetics control BP to 
<130/80 (Saydah, Fradkin, & Cowie, 2004). In this study, previously documented 
hypertension operationally confirmed presence of the disease and blood pressure control 
was measured by resting blood pressure at the time of data collection. 
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Hypercholesterolemia. Hypercholesterolemia is a condition in which excess lipids are 
found in the blood. For the purpose of this study a total cholesterol of>200mg/dL and/or 
LDL levels> 1 OOmg/dL constitute the operational definition of hyperlipidemia. 
Hyperlipidemia is also known as dyslipidemia and hypercholesterolemia in the literature. 
Smoker. A smoker is defined as a person who smokes tobacco or crack cocaine 
habitually. A documentation of crack cocaine smoking is also noted if provided by the 
resident. Residents in the sample population are not permitted to smoke while in the 
program; therefore, as the study commenced, those identified as smokers were not 
smoking at the time. The operational definition of smoker was any patient who 
previously identified him or herself as such. A pack year history or years of cigarette or 
crack use was recorded if provided by the patiicipant. 
Ankle-brachial index. An ankle-brachial index is the ratio that is obtained by establishing 
the systolic blood pressure in each ankle and dividing it by the highest brachial systolic 
pressure (Leng, Fowkes, Lee, Dunbar, & et al, 1996). For the purpose of this study, a 
patient was classified as having PAD if they had an ABI:S0.90 (Hirsch et al., 2001; Leng, 
1996). Two techniques, the gold standard, hand-held vascular Doppler and an electronic 
blood pressure machine (EBM), were used to evaluate ABI for this study. 
Peripheral arterial disease. PAD is a condition in which progressive occlusion of blood 
vessels occur, particularly in the extremities. PAD has also been expressed as peripheral 
arterial occlusive disease (PAOD), lower extremity occlusive disease (LEAD) and 
peripheral vascular disease (PVD) in the literature (Bordeaux, Reish, & Hirsch, 2003). 
Theoretical Framework 
Milio's (1976) framework for prevention provided the theoretical background for 
this study. Milio's strategies encompass concepts of health promotion and disease 
prevention central to primary care, advanced nursing practice and underserved 
populations. Basically, Milio believed that the health status of individuals largely 
depends on the appropriateness and availability (excess or deprivation) ofhealth-
promoting resources. Healthy behavior patterns result from an individual's personal 
values and available resources, either actual or perceived. Additionally, institutional 
behaviors by governmental, corporate and policy making organizations dictate 
"available" options for individuals. Consistent provision and accessibility of health-
generating behaviors instead of those that are health-damaging allow for individual 
assimilation. Education programs and related counseling promote health through 
personal, social and cultural changes. In other words, those raised to seek health care 
through the emergency department (ED) are less likely to integrate the philosophies of 
health promotion and disease prevention. If health care resources were accessible and 
available, then ED visits would diminish. 
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Success in healthcare delivery and outcomes for underserved populations require 
utilization of appropriate, timely, and culturally-sensitive healthcare and education 
including referral to social services and community based primary care services (Politzer, 
Schempf, Starfield, & Shi, 2003). Culturally sensitive education is an important measure 
necessary to facilitate positive personal values for health-generating behaviors (Milio, 
1976). Underserved populations, such as the participants in this study, infrequently if 
ever receive comprehensive management of their healthcare needs. The provision of 
acute and chronic disease management must be augmented with appropriate screening 
and education for encouragement of health-generating behaviors 
Nurse practitioners often provide community based primary care to a variety of 
populations such as the elderly, school health and disabled. Those nurse practitioners 
delivering care to the poor, homeless and underserved must be cognizant that these 
populations have an increased mortality and morbidity (Politzer et al.) and that living in 
low income and disadvantaged neighborhoods increases cardiovascular disease risk 
(Sowers, Ferdinand, Bakris, & Douglas, 2002). Primary care nurse practitioners are 
educated and trained to offer expansive preventive services to those at risk for vascular 
diseases and it is imperative that PAD is not overlooked patiicularly in a high risk, 
underserved population. 
Summary 
This chapter provided a brief introduction to PAD and the implications for 
screening a high risk, underserved population. The significance of PAD risk assessment 
and utilization of the Doppler ABI screening tool for the primary care provider were 
examined followed by a description of the study's purpose, variables and theoretical 
framework. A review of the literature is highlighted in chapter two, which will examine 
peripheral arterial disease progression in greater detail and analyze recent clinical study 
results. 
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CHAPTER TWO 
REVIEW OF LITERATURE 
11 
Peripheral arterial disease is a vascular disorder affecting eight to twelve million 
Americans and causes significant morbidity and mortality (American Heart Association, 
n.d.). Those with the disease have a fivefold increased risk of death from heart attack or 
stroke. Vascular Disease Foundation president Alan Hirsch, MD has pioneered a national 
PAD awareness campaign due to its association with significant detrimental effect on 
functional status, quality oflife and amputation risk (Hirsch et al. 2004). The disease is of 
significant importance to primary care practitioners because PAD is markedly under-
diagnosed and under-treated (Norman, Eikelboom & Hankey, 2004). High risk, 
underserved populations, with limited access to appropriate health screenings or 
therapeutic interventions often present with multiple complications that contribute to 
PAD, a manifestation of systemic atherosclerosis. 
Most patients with PAD are asymptomatic but their risk of cardiovascular events 
and death is equal to that of patients with symptomatic disease (Khunti, 2003). Diehm et 
al. (2004) acknowledge that PAD prevalence data in primary care is limited despite its 
vital impmiance to improved treatment outcomes. These researchers call for the 
development of enhanced secondary prevention strategies of cardiovascular and 
cerebrovascular events in the community. Effective screening for PAD in all primary 
care settings may increase the chance of early diagnosis and treatment. Currently, 
asymptomatic screening for PAD is not recommended (USPSTF, 2005). 
This review of the literature will examine the pathophysiology, signs and 
symptoms, risk factors and disease progression. In addition, screening and diagnostic 
methods, diversity issues and recent research findings are provided which represent the 
state of science in PAD. 
Pathophysiology of PAD 
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Atherosclerosis is the most common cause of PAD (Lewis, 2001, Sieggreen & 
Kline, 2004). Atherosclerosis, which begins as an insidious process, actually accounts for 
approximately 90% of arterial extremity pathology (Cimminiello, 2002). Endothelial 
cells lining the arterial walls may become injured through many factors including: 
smoking; diabetes; hypertension and dyslipidemia. The degenerative inflammatory 
process known as atherosclerosis begins as endothelial injury with progression of a fatty 
streak and then a fibrotic plaque which adheres to the lining and obstructs peripheral 
blood flow. Oxidized low density lipoproteins (LDL) engulfed by macrophages form 
foam cells known to be destructive to the lining of the intima. Fatty streaks are the 
accumulation of numerous foam cells. Fibromuscular lesions develop when collagen and 
smooth muscle proliferation migrate over the fatty streak leaving a fibrotic plaque that 
destroys underlying tissue. The process further decreases arterial lumen diameter and 
impedes oxygenation and organ perfusion. The sequelae of this course may lead to tissue 
necrosis and rupture ofthe vessel (Lewis, 2001; McCance & Huether, 2002). 
Narrowing and hardening of the vessel caused by atherosclerosis leads to an 
inadequate blood supply in the peripheral arteries. Exercise creates increased demand for 
oxygen. Insufficient perfusion to the vasculature creates an anaerobic state which causes 
the muscles to produce lactic acid (Meru et al., 2005). The resultant cramping and pain is 
known as intermittent claudication, which usually occurs with an ABI between 0.30-0.90 
(DeSanctis, 2001 ). 
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Signs and Symptoms 
It is estimated that approximately 75% ofPAD patients are asymptomatic. Since 
PAD is often found with advanced age or in combination with other diseases, the patient 
and provider may attribute progressive lower extremity discomfort, reduced sensation 
and limited ambulation to the aging process. Asymptomatic PAD has been associated 
with reduced quality oflife and impaired lower extremity functioning including; slower 
walking velocity, poor balance, shorter walking distances and impaired ability to 
repeatedly rise from a sitting position (McDermott, Fried, Simonsick, Ling, & Guralnik, 
2000). Without diagnosis or therapeutic intervention, development of a more advanced, 
painful stage may ensue. 
Intermittent claudication. The most common presentation of symptomatic PAD is 
intermittent claudication (IC), typically manifested by aching pain, weakness, numbness 
or fatigue in lower extremity muscle groups (Bick, 2003; Schainfeld, 2001). 
Acute claudication. Symptoms of IC initially occur during exertion and disappear during 
rest (Cassady, 2004; Cimminiello, 2002). At this stage, the patient may walk a shorter 
distance at a slower pace and experience discomfort. Diminished or absent pulses, low 
skin temperature, hair loss and poor capillary refill may also be present (Goodal, 2000). 
As the severity increases, symptoms of claudication may become debilitating reducing 
functional ability, quality oflife and altering body image. This may cause a significant 
emotional and fiscal burden to the patient, family and community. 
Critical limb ischemia. Critical limb ischemia (CLI) exists when the patient experiences 
pain at rest, exacerbated by the supine position. Relief may only be possible by placing 
the legs in a dependent position, such as dangling over the side of the bed. At this stage, 
non-healing wounds, lesions, ulcers and gangrene, which are limb-threatening 
complications of PAD, (Sheehan et al. 2003) may result, requiring revascularization 
surgery or amputation (Burns, Gough, & Bradbury, 2003). 
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Insufficient perfusion to the extremities develops due to acute obstruction or is the 
result of progressive chronic occlusion of the peripheral vasculature. Clinical 
manifestations of PAD may not be realized for decades, although the detrimental effect 
continues. Aging, toxins and comorbidities adversely affect the smooth intimal lining 
found in otherwise healthy arteries increasing the risk of developing PAD. 
Risk Factors 
Diabetes. PAD is a major factor in lower extremity amputation, especially among 
diabetics (Sheehan et. al., 2003). Diabetics and smokers are at risk for developing 
peripheral neuropathy with resultant impaired sensory perception (Sheehan et al). 
Damaged sensorineural receptors impair responses to pain and injury. Peripheral 
neuropathy often complicates the discovery of PAD (Mitka, 2004). Undiagnosed and 
uncontrolled diabetics are at an increased risk of developing the complications of 
physical walking limitations and a reduced quality of life (Olea & Sanders, 2005). 
Further, HgbAlC levels 2:5.3% are associated with higher risk of PAD (Muntner, et. al., 
2005). Diabetics have a 2-4 fold increased risk of developing PAD (NHLBI, 2003). The 
American Diabetes Association (ADA) Consensus Panel suggests that patients 2:50 years 
of age with diabetes and 2:40 years of age with diabetes and additional cardiovascular 
disease risks should be screened using the ABI (Sheehan et al.) annually since 
atherosclerosis is known to occur earlier in diabetic patients, causing reduced functioning 
of the lower extremities (Dolan et al., 2002; Gordon, 2004). 
Hypercholesterolemia. Hypercholesterolemia is present in approximately 40% of patients 
with PAD (Stiihlinger & Tsao, 2003). An increased level of LDL is associated with the 
progression of atherosclerosis which coincides with the development of endothelial 
dysfunction. Arterial occlusion is the negative sequelae of chronic, untreated 
atherosclerosis. 
Hypertension. Fifty million Americans are affected with the nation's most common 
primary diagnosis, hypertension, which also affects 50-92% of patients with PAD (Olin, 
2005). Arterioles undergo hypertrophy and hyperplasia in chronic hypertension due to 
prolonged vasoconstriction and increased vascular pressure. The resultant decrease in 
lumen diameter and stiffening of the vessels leads to an increased risk for PAD. 
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Smoldng. Valentine et al. (2004) concluded that both smokers and individuals with a 
family history of CVD were more likely to develop arterial lesions. In addition to the 
damage caused to the endothelial lining, smoking increases coagulation, exacerbating the 
progression of atherosclerosis (Bordeaux, 2003) caused by the reduction of nitric oxide 
dependent vasodilatation (Cimminiello, 2002). The incremental risk for developing PAD 
in smokers is three to fivefold (NHLBI, 2003). A systematic review of the incidence and 
prevalence of PAD by Willigendael et al. (2004) observed that smoking is reported by 
50% of patients with disease. Their analysis also concluded that former smokers have a 
2.6 fold increase in risk of asymptomatic PAD. 
Disease Progression 
Patients with PAD have a considerable increase in comorbidity burden (Kugler 
and Rudofsky, 2003 ). Patients with intermittent claudication have a 1 0-year mortality rate 
of 60% and report that the symptoms adversely affect their quality of life, functional 
status, home-management skills, social interactions and ambulation. Though rare, 
approximately 4-5% of PAD patients may have a resultant amputation (Sheehan et al. 
2003). Hirsch (2003) claims that under-diagnosis of PAD in primary care hinders 
secondary cardiovascular disease (CVD) prevention practices, including aggressive 
treatment for diabetes, hyperlipidemia, hypertension and smoking cessation. Relevant 
history taking and awareness of subtle signs are frequently overlooked in the absence of 
classic symptoms of claudication (Lesho et al., 2004). Early diagnosis of PAD is of 
critical importance because it is a powerful predictor of future cardiovascular events such 
as myocardial infarction, cerebrovascular accidents and death (Diehm et al., 2004). 
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Screening and Diagnosis 
Unless specifically questioned by the primary care provider to ascertain vascular 
health status, the signs and symptoms may remain undetected and the disease will be 
undiagnosed and untreated (Goodal, 2000). Most ofthe risk factors for PAD are 
controllable through lifestyle modification and therapeutic intervention. The most 
significant modifiable risk factor is smoking (Lesho et al., 2004). Hypertension, diabetes, 
hyperlipidemia, obesity and inactivity are additional examples of manageable risks. Non-
modifiable risk factors are advanced age, family history, male gender (Bordeaux et al., 
2003) and ethnicity (Collins, Petersen, & Suarez-Almazor, 2003). 
At all stages along the screening and diagnostic process for PAD, the practitioner 
must be cognizant of available physical and verbal assessment tools. In addition to 
performing the ABI, patient education and behavior modification are essential for patient 
commitment to a therapeutic regimen designed to reduce other cardiovascular and 
cerebrovascular events, limb loss and death. Risk factor management is the key to 
delaying the progression of PAD. Aggressive treatment of hypertension, hyperlipidemia, 
diabetes and a smoking cessation program have been routinely advocated (Treat-
Jacobson & Walsh, 2003). Routine screening in asymptomatic adults has not been 
recommended by the U.S. Preventive Services Task Force (USPSTF, 2005). Saydah et al. 
(2004) support the standards of medical care set by the ADA for the reduction of CVD 
complications in diabetics. The ADA advocates that goals for diagnosed diabetics to be 
an HgbAlc <6%, BP<l30/80, and LDL <lOOmg/dL. 
Current Research Findings 
Many recent PAD studies can be found in the literature. Reports by the Vascular 
Disease Foundation explain the necessity for mandating the creation of a national public 
awareness campaign for PAD (Hirsch et al. 2004). As is reflective of most PAD 
investigations, the sample populations used in these studies are predominantly elderly 
Caucasians. 
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In PARTNERS, an interdisciplinary, cross-sectional PAD detection program, 
investigators analyzed 6879 patients over ages 50 and older with a history of smoking or 
diabetes; in 350 U.S. primary care practices. Although there was a PAD prevalence of 
29% of patients diagnosed by an ABI of <0.90 with PAD, only 8.7% had IC symptoms. 
Primary care utilization of IC symptoms alone for PAD diagnosis will miss more than 
85% of PAD (Hirsch et al., 2001 ). Broader screening may reduce the ban-ier to effective 
secondary cardiovascular disease prevention methods. Physician awareness of prior 
diagnosis ofPAD was only 49%. PAD patients received less aggressive treatment than 
was provided CVD patients. These researchers advised that screening with a simple ABI 
measurement will identify many previously undiagnosed PAD patients and suggested that 
enhanced diagnostic efforts and appropriate therapeutic interventions in primary care 
practices are required to restrict critical limb ischemia, amputation and cardiovascular 
risk to improve quality of life. 
Researchers from the Women's Health and Aging Study (WHAS) analyzed the 
prevalence of asymptomatic PAD among 1002 community dwelling, disabled women 
between 65-85 years of age (McDermott et al., 2000). The authors reported the 
prevalence of ABI<0.90 to be 35% ofthe target population. Also noted was that the 
majority of patients with PAD did not experience exertionalleg pain, but lower ABI 
levels were related to progressively poorer functioning of the lower extremities 
(McDermott et al.). The General Internal Medicine (GIM) study, conducted by the same 
primary investigator focused on 382 men and women over 55 years of age. They found 
undetected PAD in 14% of the patients and in previously diagnosed patients, only 44% 
had exertionalleg symptoms. Cigarette smoking was significant in undiagnosed PAD 
patients (McDermott et. al., 2001). Finally, these investigators attributed functional lower 
extremity impairment to undiagnosed PAD patients and concluded that without ABI 
screening, PAD is difficult to diagnose. 
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The German Epidemiological Trial on Ankle Brachial Index (getABI study), was a 
large-scale, cross sectional study in which investigators assessed 6,880 men and women 
(mean age 72.5 years) in German general medicine practices (Diehm et al., 2004). An 
analysis of ABI, physical exam, comorbidities and the WHO questionnaire on 
intermittent claudication were performed to determine the prevalence and cormorbidity of 
PAD. Researchers concluded that history and physical examination of a patient are 
insensitive for diagnosing PAD and recommended ABI screening. Eighteen percent of 
their sample population had an ABI<0.90, with a higher prevalence in men (19.8%) than 
women (16.8%). The prevalence ofPAD patients with CVD, diabetes, hypertension, 
hyperlipidemia and a history of smoking were also higher than in those without PAD. As 
has been found in other studies, the WHO/Rose questionnaire on intermittent claudication 
only confirmed 11% of the PAD patients (Leng & Fowkes, 1992). 
Researchers in another study compared comorbidity and quality oflife indices of 
101 symptomatic men and women (mean age 66.4) with those of 89 asymptomatic 
community-dwelling elderly individuals (mean age 77.4) and 439 geriatric nursing home 
residents (mean age of 84.1 ). Comorbidity indices and illness severity using the 
cumulative illness rating scales (CIRS) were significantly higher in the symptomatic 
PAD patient group. Additionally, quality oflife subjective health status scores worsened 
with advanced stages of PAD and IC. In fact, researchers indicated the 10-year mortality 
rate associated with IC might be as high as 60% (Kugler & Rudofsky, 2003). 
The Atherosclerosis Risk in Communities Study (ARIC) was a prospective cohort 
study identifying PAD risk factors in 15,972 patients with diabetes, ages 45-64 years. 
Participants were white and black men and women represented from four communities 
throughout the United States. Analysis of study participants was conducted over a 10.3 
mean year period at three year intervals. Of the participants with diabetes, 238 developed 
PAD. A low ABI was the only means by which PAD was detected in 110 of the 
participants. The study concluded that the risk of developing PAD in diabetics was 
increased 1.87-fold (95% CI, range 1.36-2.57). In current smokers, the risk increased to 
2.27 (95% CI, range 1.57-3.26) and in participants with baseline CHD, a 1.75-fold 
increased risk (95% CI, 1.18-2.60) was demonstrated (Wattanakit, K. et al., 2005). 
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The prevalence oflower-extremity disease in U.S. adults' 2:40 years of age 
regardless of diabetic status was reported by Gregg et al. (2004) based on the 1999-2000 
National Health and Nutrition Examination Survey. This study concluded that 4.5% of 
participants had lower-extremity disease. PAD was twice as common in diagnosed 
diabetics-9.5%, and affected the elderly, non-Hispanic blacks and Mexican Americans in 
greater proportion. Each gender was represented equally in this sample of 2,873 men and 
women with a mean age were 56.9 years. The population was 75% white, 9.6% black and 
4.5% Hispanic. Diabetes had been diagnosed in 9.9%, hypertension in 36%; CVD in 
11.5% and 53% had a history of smoking. The study concluded that their prevalence rate 
of PAD, which is lower than reported by most studies, was due to the younger age of 
their sample population. A call for increased assessment, prevention and CVD 
management efforts were recommended (Gregg, et. al., 2004). 
A study of racial diversity as it relates to the prevalence of PAD was reviewed. 
Four hundred and three Caucasians, African Americans and Hispanics > 55 years of age, 
residing in lower income households near four Houston primary care clinics were 
screened (Collins et al., 2003). Physical assessment including an ABI, difficulty with 
walking, medical history and quality of life were performed in addition to evaluation of 
questionnaires concerning symptoms of IC. The prevalence of PAD in Afi·ican 
Americans (22.8%) was higher than in Caucasians and Hispanics (13.5%) with a 
combined total of 18% PAD in the general medical practice. Smoking (29 .9% ), diabetes 
(55.2%) and hypertension (82.1 %) were all more prevalent in patients diagnosed with 
versus patients without PAD. Prior PAD diagnosis was more likely in Caucasians than 
African Americans or Hispanics. Asymptomatic PAD was found in 3 7% of the diagnosed 
patients. Researchers found the San Diego Claudication Questionnaire (SDCQ) and the 
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Walking Impairment Questionnaire (WIQ) individually to have low sensitivity for PAD 
when compared to ABI, the gold standard for diagnosis due to the late onset of 
symptoms. Quality of life scores for physical function and role limitations were 
significantly lower in PAD patients. Concern for quality of life in chronic illness 
prompted the authors to promote the ABI screening tool for CVD at risk patients. Collins 
et al. observed that African Americans have approximately two times the prevalence of 
PAD than Caucasians and Hispanics. Though little PAD research has been conducted 
with diverse populations, further studies have been suggested to clarify the actual 
prevalence, especially in the medically underserved. 
Researchers in the Atherosclerosis Risk in Communities Study reported that the 
incidence of PAD in African American women with Type 2 diabetes is 2.4 times that of 
Caucasian women aged 45-64 years (Sowers et al., 2002). The prevalence of 
hypertension and CVD is also reported to be substantially higher in African Americans. 
Environment, diet and access to health care contribute to an earlier onset of CVD with 
increased mortality rates (Sowers et al.). Additionally, the uninsured, underserved 
population is less likely to seek health care until disease progression has deteriorated 
significantly (Hafner-Eaton, 1993). Therefore, those who are poor should anticipate more 
chronic illnesses and a decreased lifespan (Politzer et al, 2003). 
Though no major clinical research studies have been conducted on the association 
of cocaine or crack and PAD, two patients with cocaine-induced peripheral vascular 
occlusive disease were reported in a case study by Gutierrez, England and Krupski, 
(1998). One 3 7 year old man presented within hours of smoking crack cocaine 
complaining of severe pain and numbness in both feet. Although intervention was 
extensive, he eventually required bilateral below the knee amputations. The second 
patient was a 22 year old female with bilateral pedal burning pain and numbness who 
presented within an hour of smoking crack cocaine. As with the previous patient, both of 
her feet were cold with diminished peripheral pulses. After treatment, the second patient 
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suffered no long-term negative sequelae. Cocaine's effect causes intense 
vasoconstriction, increased atherogenicity and dysfunctional production of relaxin factor 
production in the endothelium according to these authors. Gutierrez et al. acknowledge 
that cocaine-induced coronary artery vasoconstriction is well documented, but its 
influence on the peripheral vasculature warrants further investigation. 
Summary 
Each of the PAD studies reviewed indicates a high prevalence of an undiagnosed, 
asymptomatic condition often overlooked in primary care practice. The research has 
focused mainly on elderly Caucasians. Though the prevalence ofPAD increases with age, 
underserved populations suffer a dispropotiionate burden of chronic illness including 
hypertension, diabetes and CVD. PAD, which is a systemic manifestation of 
atherosclerosis, presents often with other CVD comorbidities, patiicularly in smokers. 
Broader screening measures, including the gold standard ABI, have been advocated by 
many experts interested in early detection of PAD in order to promote vascular health and 
maintain quality oflife (Heidrich, Wenk, & Hesse, 2004). This coincides with Milio's 
framework for prevention, which challenges the health care delivery system to provide 
state of the art modalities and promote health-generating behaviors in underserved 
populations. 
CHAPTER THREE 
METHODOLOGY 
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The purpose of this cross sectional descriptive study was to determine the 
prevalence of PAD in a high-risk, underserved predominantly African American 
homeless population and to determine if an electronic blood pressure machine could 
accurately measure ABI. The assessment will be done through physical examination, the 
San Diego Claudication Questionnaire (SDCQ) and ABI analysis. The sample population 
was largely African Americans who are at greater risk for developing cardiovascular 
diseases. A comparison of hand-held Doppler blood pressure readings versus the use of 
an electronic blood pressure machine for ABI assessment was conducted. The review of 
literature indicated that the prevalence of PAD is as much as 29% (Hirsch et al., 2001) in 
the primary care setting. Hypertension, hyperlipidemia, diabetes and cigarette smoking 
compound the risk for PAD, cardiovascular disease and cerebrovascular events. As has 
been documented, PAD is underdiagnosed and undertreated in the primary care setting. 
Given that the majority of patients are asymptomatic or have atypical presentations, 
secondary prevention strategies are limited. Evaluation of diabetics for PAD may be 
more difficult due to decreased sensory perception from peripheral neuropathy and distal 
vessel lesions, though the incidence of PAD in diabetics is more prevalent than in 
nondiabetics. Reduction of dyslipidemia and hypertension are advised to reduce the risk 
of claudication and to promote cardiovascular health. The most important modifiable 
cardiovascular risk factor is smoking. Tobacco use is highly associated with the 
development and exacerbation of PAD. Smoking is also linked to the progression of 
atherosclerosis and an increased amputation risk (Sheehan et al., 2003). This chapter will 
discuss the methodology used in this study. 
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Sample 
A nonprobability convenience sample of patients at a local shelter was used. 
Confirmed diagnoses of diabetes, hypertension, hyperlipidemia or history of cigarette or 
crack cocaine smoking, regardless of age, were the inclusion criteria. A confirmed 
diagnosis was assumed if documentation in the participant's chart was established and/or 
the patient was receiving medication for diabetes, hypertension or hyperlipidemia. 
Additionally, laboratory or diagnostic values were considered evidence of disease 
for inclusion criteria in the following instances. Hypertension was assumed if the patient 
had two or more systolic blood pressures of> 129 or a diastolic blood pressure of >80 
(Ebell, 2004). History of smoking was established by patient confirmation of prior usage 
and a years used or pack year value was determined. Hyperlipidemia was assumed if 
LDL values were> 100 and/or total cholesterol was >200. Fasting blood glucose (fbg) 
over 126 was diagnostic of diabetes. 
The target population was predominantly African American, previously homeless, 
indigent, many with substance abuse histories and limited access to sufficient, 
appropriate health care, health promotion or disease prevention programs. This group is 
reflective of the high-risk underserved population in northeast Florida. Available patients, 
who met the study criteria and gave their consent for participation, represented the 
sample population 
Setting 
The setting was the medical clinic at a local shelter which is a faith-based, recovery 
residence for the homeless and needy in Northeast Florida. In addition to medical care, 
residents were provided with counseling, education or vocational training and Bible 
study. The clinic had three patient examination rooms, a nurse's assessment station, a 
pharmacy and a front office. The facility was adequately equipped to accommodate the 
proposed study. 
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Data Collection 
The primary investigator conducted all steps of the procedure unless otherwise 
noted. Review of current patient charts and new patient initial assessments identified the 
potential sample. Based on inclusion criteria, patients were asked to participate in the 
study through direct contact by the researcher. The study purpose and procedures were 
explained and a written consent to participate was obtained (see Appendices A and B). 
Once consent was obtained, participants were given an appointment for testing. A 
physical assessment, patient history and San Diego Claudication Questionnaire results 
were collected and documented. An ABI assessment was obtained on every participant. 
The systolic blood pressures from bilateral brachial arteries and from either the dorsalis 
pedis or posterior tibialis of both ankles were recorded. The ABI Doppler assessment and 
electronic blood pressure measurements were assessed by the primary investigator, a 
skilled practitioner, using the standard procedure (See Table 3.1). Interpretation of ABI 
ratio readings is presented Table 3.2. Each participant with an ABI:S0.9 was referred to 
the medical clinic director and/or a vascular specialist for further evaluation. 
Table 3.1 
Step 1 
Step 2 
Step 3 
Step 4 
Step 5 
ABI Measurement Procedure 
Rest patient in supine position for five minutes 
Bilateral brachial systolic BP taken at antecubital fossa using stethoscope 
and BP cuff, the higher reading will be used to calculate ABI 
Place appropriate size cuff around right ankle 
Obtain BP using Doppler at dorsalis pedis or posterior tibialis arteries 
Repeat step with left ankle 
ABI is calculated by dividing the higher ankle systolic BP for each leg 
By the highest brachial systolic BP, record results 
Repeat procedure using the EBM, record results 
(Sheehan et al. 2003; Weber & Kelley, 2003) 
Table 3.2 ABI Interpretation Results 
0.91 to 1.30 
::=:;0.90 
>0.80 to ::=:;0.90 
0.50 to 0.80 
<0.50 
Normal 
Abnormal 
Mild disease, possibly asymptomatic 
Moderate disease 
Indicative of severe occlusive disease 
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ABI 
ABI 
ABI 
ABI 
ABI 
ABI 
ABI 
<0.25 
>1.30 
Typically indicative of ischemic rest pain or tissue loss 
Poorly compressible arteries from calcification in diabetes 
(Sheehan et al., 2003) 
Instruments 
Two written instruments were used for this study, a data collection form was 
developed by the primary investigator (see Appendix A) and the San Diego Claudication 
Questionnaire (SDCQ) (see Appendix B). The data collection form reflected pertinent 
diagnoses, physical assessments and clinical impressions. The SDCQ, developed by 
Michael Criqui, MD, is based on the WHO/Rose intermittent claudication questionnaire 
and has documented reliability and validity (Criqui et al., 1996). The difference between 
the SDCQ and the WHO/Rose questionnaire is that the SDCQ is able to provide an 
evaluation for bilateral results. The questionnaire was administered verbally or given as a 
self-test, to assess if each patient had no pain, was asymptomatic, had symptomatic PAD 
or intermittent claudication, which is also identified in the literature as Rose or typical 
claudication. The SDCQ is an enhanced version of the widely used WHO/Rose 
intermittent claudication questionnaire developed in 1962 by Leng and Fowkes (1992). 
Studies have shown the WHO/Rose questionnaire to have a sensitive of 60-68% and a 
specificity of90-100% (Cimiminiello, 2002). The SDCQ incorporates revisions made on 
the WHO/Rose questionnaire to include the evaluation of buttock, thigh and right or left 
leg specific symptoms. Permission for the SDCQ use was provided by Dr. Criqui (see 
Appendix C). 
Ankle-brachial index, the ratio of the ankle systolic pressure to the brachial systolic 
pressure was ascertained. This objective test measures the lower extremity arterial 
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perfusion (DeSanctis, 2001). It has 91.3% sensitivity and 99.3% specificity (Leng & 
Fowkes, 1992). Instruments used to obtain the brachial and ankle blood pressures were a 
hand-held 5-10 MHz Doppler and an EBM. The Welch-Allyn Propaq 102 EL vital signs 
monitor was the EBM used in this study. The hand-held ultrasound Doppler used for this 
study was the Nicolet Vascular Elite model #100 with an 8MHz probe. Both instruments 
have been inspected for accuracy and reliability to conform to American Standards for 
Testing Materials (ASTM) guidelines. 
Statistical Analysis 
A descriptive statistical analysis was conducted to evaluate the data utilizing SPSS 
v 14.0 software. The level of data collected and the anticipated findings are provided (See 
Table 3.3) including research questions and the demographic data. 
Protection of Human Subjects 
The Institutional Review Board (IRB) of the University ofNorth Florida approved 
the design and intent of this study for the protection ofhuman subjects. Each subject, 
prior to participati?n in the study, completed an informed consent document (see 
Appendix D). The right to refusal from participation in the study without penalty was 
offered to each study participant as was the option to discontinue participation at any 
point. 
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CHAPTER FOUR 
RESULTS 
The purpose of this study was to describe the prevalence of PAD in an 
underserved, high-risk, predominantly African American, homeless population and to 
determine if the electronic blood pressure machine (EBM) could accurately measure ABI 
compared to findings obtained by Doppler technique. Over a period of fifteen months, 
medical clinic patients were evaluated and 56 were enrolled in the study based on 
eligibility criteria. Due to the transient nature of the shelter, 16 enrollees were unavailable 
at the time the clinical data were gathered. The total sample size, therefore, was 40. 
Demographic Data 
The study was conducted at the medical clinic of a residential shelter for the 
homeless. The average age of the sample was 46.03 years (range =20-59 SD = 9.09). The 
sample population was 70% male (n=28). Twenty-seven (67.5%) were Black, 12 (30%) 
were White, and 1 (2.5%) was Hispanic. The mean BMI of the 38 patients for whom 
these data were available was 29.78 (range= 20.64 to 64.7, SD 8.22). 
Figure 4.1 Descriptive statistics 
Gender (n=40) 
30 
1/) 25 ... c:: 
Q) 
i 20 
D. 
.... 15 0 
IIIII Male70% 
... 
Q) 10 ,Q 
0 Female30% 
E 
:I 5 z 
0 
Figure 4.2 Descriptive statistics 
~25r----------------
GI 
'.0 20 +--------------
r:. 
0 15 r--------,---
j -x>r----
e i 5+-----
0+-----
Risk Factors 
Race (n=40) 
a White 30% 
aBiack67.5% 
D Hispanic 2.5% 
Hypertension, diabetes, hypercholesterolemia and a history of smoking are the 
comorbidities of cardiovascular disease which were identified and utilized as the 
eligibility criteria (See Table 4.3). 
Hypertension. Of the study participants 55% (n=22) had a diagnosis of hypertension. 
Twenty of these (90.91 %) were on antihypertensive medications. Ten ofthose patients 
were on two antihypertensive medications and two patients were on three 
antihypertensive medications. Of the 22 patients on reported antihypertensive 
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medications, only six had a systolic blood pressure under 120mmHg and a diastolic blood 
pressure below 90mmHg. 
Hypercholesterolemia. Forty-two percent (n=17) of the sample population had a 
diagnosis ofhypercholesterolemia. Eleven of these (64.71 %) were on antilipidemic 
medications. The serum cholesterol readings revealed that four patients had a total 
cholesterol level under 200mg/dl and five patients had a low density lipoprotein level 
below 100. 
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Diabetes. Twelve patients (30%) had a diagnosis of diabetes. All twelve patients were on 
either oral glucose lowering medications or insulin. Only two patients however, had an 
HgbA1 C under 6.0% or fasting blood glucose under 1 OOmg/dl. 
Smoldng. Eighty percent (n=32) had a history of cigarette smoking prior to their residence 
at the shelter. A prior habit of smoking crack cocaine was reported by 85% (n=34). 
Table 4.3 Risk Factor Analysis 
Risk factor Number Percent Minimum Maximum Mean Std Dev N 
Age 40 100 20 59 46.03 9.09 40 
BMI 40 100 20.64 64.70 29.78 8.22 38 
Hypertension 22 55 
Systolic BP 102 194 140.45 22.85 22 
Diastolic BP 64 110 87.45 11.35 22 
Hyperlipidemia 17 42 
Total 153 298 215.19 42.08 16 
LDL 58 189 124.70 40.91 15 
Diabetes 12 30 
Fasting glucose 89 401 198.67 92.83 12 
HgbA1C 5.4 18.10 8.27 2.68 12 
Smoking 
Cigarette-pk yrs 32 80 1 80 26.69 18.67 29 
Crack yrs of use 34 85 0.1 25 9.25 7.63 22 
Clinical Assessment 
Lower extremities were examined in all study participants with an evaluation of dorsalis 
pedis and posterior tibialis pulses, pedal temperature, hair loss, capillary refill, thickened 
toenails, shiny or scaly skin, lesion, ulcer or gangrene, sensory perception and edema was 
assessed. Bilateral adverse assessment findings were recorded (see Figure 4.3 and Figure 
4.4). 
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Figure 4.3 Bilateral Extremity Assessment I 
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San Diego Claudication Questionnaire. Thirty-nine of the forty participants completed 
the questionnaire. Evaluation of questionnaire results using criteria provided by the 
author revealed that four participants had symptoms consistent with claudication, one 
participant had non-Rose calf pain, 25 participants had pain at rest, 9 pmiicipants 
reported no pain and one participant did not complete the questionnaire (n=39) (See 
Figure 4.5). 
Figure 4.5 San Diego Claudication Questionnaire Results 
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Ankle-brachial index. The ankle-brachial index was obtained on both the right and left 
extremity of each study participant using the Doppler method and the electronic blood 
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pressure machine. Using the standard Doppler method, a reading of ::;.90 was obtained in 
the right extremity of five study participants (12.5%) and in the left extremity in six 
participants (15%), for a total of22.5% ofthe sample population. Two participants had 
bilateral disease. The electronic blood pressure machine indicated no study participants 
with an ABI of .90 or lower. Using the Doppler, two right (5%) and two left (5%) 
extremities revealed an ABI> 1.30 while the electronic blood pressure machine revealed 
an ABI> 1.30 in four right (1 0%) and seven left (17.5%) extremities. This is indicative of 
non-compressible vessels associated with diabetes. 
Table 4.4 presents the demographic data, number of risk factors, results from the San 
Diego Claudication Questionnaire (SDCQ) and bilateral ABI results using both the gold 
standard hand-held Doppler and the electronic blood pressure machine for each study 
participant with an ABI ::;.90. 
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Table 4.4 Abnormal ABI Results (ABI:S0.90*) 
Pt Dem #RF SDCQ ABI by Doppler ABI Electronic BP 
1 48bm 3C Rest R 0.900* L 1.070 R 1.090 L 1.180 
3 37wm 1C Claudication R 1.118 L 0.847* R 1.190 L 1.340 
4 45bm 3C None R 0.927 L 0.900* R 1.238 L 1.247 
8 56bm 2C None R 0.980 L 0.740* R 0.990 L 0.915 
30 45bm 4C Rest R 1.060 L 0 .830* R 1.230 L 1.210 
31 50bm 4C Claudication R 0.720* L 0 .909 R 1.090 L 1.009 
33 56bm 3C None R 0.900* L 1.010 R 1.240 L 1.130 
35 54bm 2C None R 0.680* L 0.780* R 1.050 L 0.920 
40 30wm 1C Claudication R 0.690* L 0.845* R 1.040 L 0.970 
Discussion 
All of the study participants with an abnormal ABI were male. Seven of the nine 
men (78%) with abnormal ABis were black and 22% (n=2) were white. The mean age of 
these participants was 46.78 with a minimum age of 30 years and a maximum of 56 
years. Eighty-five percent of the entire sample population had a history of crack cocaine 
use, but in those with an abnormal ABI, 100% had a history ofusing crack cocaine. 
Three participants, or 33% reported results consistent with claudication on the SDCQ and 
only two participants, or 22% had bilateral abnormal ABis. Using the EBM, no reports of 
an abnormal ABI were obtained. 
CHAPTER FIVE 
CONCLUSION 
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The objective of this study was to identify the prevalence of PAD in residents at a 
local homeless shelter and to determine the efficacy of using an electronic blood pressure 
machine to accurately assess ABI. All study participants were identified to have at least 
one of the risk criteria ofhypettension, hypercholesterolemia, diabetes or a history of 
smoking. It is difficult to determine if this sample is generalizable to national high risk, 
underserved homeless populations due to an inability to accurately gather census data, 
however, the study population is reflective of the homeless population at this resident 
shelter in Northeast Florida. 
The importance of this study is the unique view provided professionals of an 
infrequently studied population since health status analysis of the homeless is complex 
and rarely reported. National disease prevalence ofP AD has been established 
predominantly through studies with participants who are older, Caucasian and insured. A 
29% prevalence of PAD was reported by the PARTNERS study, but it is essential to 
restate that the average age ofthat sample was 70 years (Hirsch et al., 2001). The 
National Health and Nutrition Examination Survey reported a lower-extremity prevalence 
of 4.5% and a 9.5% respectively in diabetics and non-diabetics (Gregg, et. al., 2004). The 
prevalence oflower-extremity PAD, indicated by an ABI:S0.90 in this sample, with a 
mean age of 46.03 years was 22.5% at this local resident shelter in Northeast Florida. 
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This significance of this finding is reflective of the sample population which is 
70% male, 70% non-white and 100% homeless. None of the participants had medical 
coverage or consistent healthcare. The cardiovascular and cerebrovascular risks suffered 
by the participants in the study were hypertension-55%, hypercholesterolemia-42% and 
30% diabetes. A striking 80% had a history of smoking cigarettes and 85% had a history 
of smoking crack cocaine. 
The use of the electronic blood pressure machine indicated that no study 
participants had an ABI:S0.90. Furthermore, it is important to reiterate that all study 
participants were evaluated using both the Doppler and electronic blood pressure 
machine. The electronic blood pressure machine was found in this study to be an 
insensitive tool in identifying PAD using the ABI method. 
Limitations 
The small sample population and the extended period of time that the data was 
gathered combined with the transient nature of the shelter population limited the ability to 
achieve exact point prevalence. A probability sample was not possible for this study since 
the identity and location of all high-risk underserved individuals in northeast Florida is 
unknown, which is a limitation of the study. Some data were not available when the 
results were tallied and 16 people whom had given their consent were no longer available 
for further investigation at the time the study was conducted. Four individuals, who met 
the criteria, declined participation. The study excluded individuals without the known 
CVD risk factors of hypertension, hypercholesterolemia, diabetes or a history of smoking 
potentially resulting in altering the identified prevalence of PAD. The participants were 
required to refrain from smoking once they entered the residence which may improve 
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their ABI. Also, no documentation of duration since diagnosis of risk factors or length of 
treatment was evaluated and no documentation on various test results (e.g. blood 
pressure, HgbalC, LDL) was gathered unless the pmiicipant had a diagnosis of the 
specific comorbidity. Most study patiicipants completed their own SDCQ allowing for 
the introduction of error due to interpretation. An interviewer administered questionnaire 
was offered to every participant. 
Implications for Further Study 
The results of this study clearly indicate the importance of further research in the 
investigation of PAD on a larger scale in an underserved, high risk population. Special 
attention should be given to the high risk population who are currently smoking and using 
illicit drugs on a regular basis. The prevalence of PAD in those without known risk 
factors is of interest since many who are homeless and underserved are unaware that they 
have certain diseases known to predispose them to PAD. 
Conclusion 
In conclusion, the appearance of risk factors in an underserved high risk 
population identifies a significant percentage of individuals with peripheral arterial 
disease. The prevalence of 22.5% is higher than nationally reported given the average age 
of 46.03 years in this study. The sample population is much younger than currently 
studied and available in the literature for this disease process. Unlike all published studies 
on peripheral arterial disease, little data is known about the correlation ofunderserved 
populations and illicit drug use and the prevalence of PAD. Screening those at risk for 
PAD using the Doppler ABI assessment technique is non-invasive, inexpensive and well 
tolerated. It is an impmiant tool which can be utilized to reduce the risk of CVD and 
amputations and maintain quality of life. 
Primary care nurse practitioners, providing services in the community to an 
underserved population, may have limited time and resources for adequate assessment 
and therapeutic intervention. Secondary and tertiary prevention strategies based on 
patient needs must incorporate education and health-promotion relative to the 
individual's personal values, according to Milio's framework (1976). Furthermore, the 
nurse practitioner must advocate for corporate and governmental policies that promote 
health and resources for all citizens. 
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APPENDIX A 
DATA COLLECTION FORM 
Patient's initials: DOB: Sex: Race: 
HTNDx: BP: BPMed: 
HLIPID Dx: Tchol: Ldl: Hlipid Med: 
DMDx: Fbg: HgbAlc: DMMed: 
Smoker: Pacldyear history 
PHYSICAL ASSESSMENT (Document presence/absence/charactenstlC) 
Right foot/leg Assessment Criteria Left foot/leg 
Posterior tibialis pulse 
Dorsalis pedis pulse 
Low skin temperature 
Hair loss 
Capillary refill 
Thickened toenails 
Shiny/scaly skin 
Lesion/ulcer/ gangrene 
Sensmy perception 
Edema 
ABI CALCULATION Doppler Electronic BP 
Brachial systolic: Right: Left: R: L: 
Dorsalis Pedis: R: L: ABI: R: L: ABI: 
Posterior Tibialis: R: L: ABI: R: L: ABI: 
Take highest ankle systolic per leg/highest of both brachial systolic= ABI Ratio 
APPENDIXB 
SAN DIEGO CLAUDICATION QUESTIONNAIRE 
(INTERVIEWER ADMINISTERED VERSION) 
Right Left 
1) Do you get pain or discomfort in either leg or either No 1 1 
buttock on walldng? 
Yes 2 2 
(If no, stop) 
2) Does this pain ever begin when you are standing still No 1 1 
or sitting? 
Yes 2 2 
3) In what part of the leg or buttock do you feel it? 
a) Pain includes calf/calves No 1 1 
Yes 2 2 
b) Pain includes thigh/thighs No 1 1 
Yes 2 2 
c) Pain includes buttoclv'buttocks No 1 1 
Yes 2 2 
4) Do you get it when you walk uphill or hurry? No 1 1 
Yes 2 2 
Never walks uphill/hurries 3 
5) Do you get it when you walk at an ordinary pace No 1 1 
on the level? Yes 2 2 
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6) Does the pain ever disappear while you are walking? No 
Yes 
1 
2 
7) What do you do if you get it when you are walking? Stop or slow down 1 
8) What happens to it if you stand still? 
(If unchanged, stop) 
9) How soon? 
Continue on 
Lessened or relieved 
Unchanged 
10 minutes or less 
2 
1 
2 
1 
More than 10 minutes 2 
Answer Key 
1) No pain- 1=1 
2) Pain at rest-1=2 and 2=2 
3) Non-calf-1=2 and 2=1 and 3a=1 and 3b=2 or 3c=2 
4) Non-Rose calf-1=2 and 2=1 and 3a=2, and not Rose 
5) Rose-1=2 and 2=1 and 3a=2 and 4=2 or 3 (and if 4=3, then 5=2) 
And 6=1 and 7=1 and 8=1 and 9=1 
1 
2 
1 
2 
1 
2 
1 
2 
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APPENDIXC 
AUTHORIZATION FOR USAGE OF SAN DIEGO CLAUDICATION 
QUESTIONNAIRE 
Dr. Criqui, 
I read with interest several articles you authored or co-authored on PAD. I am a 
nurse practitioner candidate at the University of North Florida and would like to 
possibly use the San Diego claudication questionnaire for a study which I will 
shortly begin. Will you please advise me how to get access and permission to use 
the questionnaire in my study? Thank you in advance for your help. 
Laura M. Triola, MAS, RN 
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Hi Laura, Both interviewer and self administered versions attached. Feel free to use. MC 
Michael H. Criqui MD, MPH 
Professor and Vice-Chair 
Dept. ofFamily and Preventive Medicine 
Appendix D 
UNIVERSITY OF NORTH FLORIDA 
JACKSONVILLE, FLORIDA 
HUMAN RESEARCH CONSENT FORM 
TITLE: Peripheral arterial disease screening of a high-risk underserved population 
INVESTIGATORS: Laura Triola, RN 
AFFILIATIONS: University ofNorth Florida School ofNursing 
CONTACT INFORMATION: Laura Triola, RN 1209 Salt Creek Island Drive 
Ponte Vedra FL 32082 904-273-1279 
Deloris Irvin School ofNursing 904-620-2680 
APPROVED BY INSTITUTIONAL REVIEW BOARD: 
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This is an important form. Please read carefully. It tells you what you need to know about 
this research study. If you agree to take part in this study, you need to sign this form. 
Your signature means that you have been told about the study and what the risks are. 
Your signature on this form also means that you want to take part in this study. 
Your participation in this research is entirely voluntary. Refusal to participate in this 
research will involve no penalty or loss ofbenefits to which you otherwise are entitled. 
You may discontinue participation in this research study at any time without penalty or 
loss ofbenefits you are otherwise entitled to. 
What is the purpose of this study? 
The purpose of this study is to determine the amount of Peripheral Arterial Disease 
(PAD) or severe leg problems, at this clinic. 
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How many participants will take part in this study? 
We hope to enroll thirty-five to fitfy participants will participate in this study. 
What will happen in this study? 
If you are able and choose to be in this study, your medical records will be reviewed 
to see if you have high blood pressure, high cholesterol, diabetes and history of 
smoking. You will be asked to answer some questions about your legs and if you 
have any pain when you walk or exercise. A brief examination of your legs and feet 
will be performed. Blood pressure readings in your arms and legs will be taken 
using two machines. An ankle-brachial index will be calculated from the blood 
pressure readings and will help determine your risk of PAD (severe leg problems). 
How long will I be in the study? 
The procedure described above will take approximately one hour and will be 
conducted over the next eighteen months to two years. 
Are there reasons I might leave the study early? 
Taldng part in this study is your decision. You may decide to stop at any time. You 
should tell me if you wish to stop participation in the study or you may be asked to 
discontinue participation if it is in your best interest to do so. 
What are the risks of the study? 
There are no apparent risks to participation in this study. Some discomfort may 
occur while you are lying flat or when the blood pressure cuff is inflated (pumped 
up). 
What happens if I am injured because I took part in this study? 
No physical or emotional injuries are anticipated 
(If more than minimal risk, will I be compensated if injured? Will medical treatment be 
provided? If so, what will it consist of? Where can I get further information on this 
matter?) 
N/A 
Are there benefits to taking part in this study? 
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Because this is a screening test, the results may indicate that you have a potential 
problem with circulation (blood flow) in your legs. If that happens, we will help you 
get an appointment for follow-up treatment. 
What other choices do I have if I do not take part in this study? 
You may continue to receive your regular medical care. 
Are there any monetary or other compensation or inducements for my taking part in this 
subject? 
None. 
Are there any financial costs to me to take pmi in this study? 
If you are referred to medical care for follow-up based on the screening, that care 
will be paid the same way as if you were not participating in the study. 
What are my rights if I take part in this study? 
You do not have to take part in this study; but if you do, you can stop at any time. 
You will be told of important new findings or any changes in the study or 
procedures that may affect you. You do not give up any of your rights by taldng 
part in this study. 
What about confidentiality? 
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Data from this study may be published or used in publications. However, your name 
and other identifying information will not be sent outside of UNF without written 
permission unless the law allows it. 
EXPLAIN YOUR METHOD FURTHER 
The ankle-brachial index involves using a blood pressure cuff and special 
stethescope to take your blood pressure in each arm and each ankle. From this a 
number is calculated indicating your risk for PAD (severe leg problems). 
Will there be audiotaping or videotaping? If so, will I get to view them before they are 
used? Who will review tapes besides the researchers? Who will have access to the tapes? 
When will they be destroyed? 
(Note- If tapes are to be used outside of the research project, a separate release form 
should be obtained.) 
No videotaping or audiotaping will be included in this study. 
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Who can answer my questions? 
You may talk to Laura Triola, RN at any time about questions and concerns you 
may have about this study. You may contact Laura Triola, RN at the University of 
North Florida School of Nursing, (904) 620-2685. You may also call Dr. Jan Meires, 
faculty mentor at 620-1469. 
You may get further information about UNF policies, the conduct of this study, the 
rights of research subjects or if you suffer injury related to your participation in this 
research project from the Institutional Review Board Chairperson, Dr. Kathaleen 
Bloom, at (904) 620-2685. 
I have had an opportunity to have my questions answered. I have been given a copy of 
this form. I agree to take part in this study. I am over 18 years of age. 
I am at least 18 years old. ____ (initials) 
I have had the study that I am agreeing to participate in explained to me to my 
satisfaction. ___ (initials) 
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I have had the opportunity to ask any questions that I may have had regarding this study. 
_____ (initials) 
I agree to participate in (study name) Peripheral arterial disease study being 
conducted by (PI) _....;:L::..:a::..:u;:;.:r-=a'-'T::;...:r:...:;io.;;;..:l:.::a""', RN=.:........- and the University of North Florida. 
Date Printed Name ofParticipant 
Signed Name ofParticipant 
Date Printed N arne of Individual Obtaining Consent 
Date Signed Name oflndividual Obtaining Consent 
APPENDIXE 
Consent to Participate in Research Script 
You have been asked to participate in a study. 
Purpose: The purpose of this study is to find out how many residents have severe leg 
problems or peripheral arterial disease (PAD). 
Duration: The study will be conducted over an 18-month period. You will be asked to 
undergo a physical exam and answer a questionnaire that will take about two hours of 
your time. 
Procedure: If you agree to participate, you will: 
1) Be asked questions about your health. 
2) Have a physical exam taken of you legs and feet. 
3) Answer a nine-item questionnaire. 
4) Have blood pressure readings taken of your arms and legs using two 
different machines. 
Eligibility: A resident is able to participate if he or she has any of the following 
conditions. 
1) High blood pressure (hypertension) 
2) High blood sugar (diabetes) 
3) High blood fats (hyperlipidemia) 
4) History of smoking 
We hope to enroll 35-50 participants in this study. 
Risks: There are no known risks to participation in this study. 
Benefits: This screening tool will help to identify a severe leg problem. 
Alternative Care: Participation in this study is totally voluntary. If you decide not to 
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participate in this study you will continue to receive care at the medical clinic as you did 
previously. 
Confidentiality: All records will be kept confidential. No publications will contain 
specific patient information. Your identity will not be disclosed. 
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If you have any questions or concerns, please contact me, Laura Triola, RN at 904-273-
1279 or Dr. Jan Meires at the University ofNorth Florida 904-620-1469. 
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